What is Sales and Marketing Strategy of Fosun Pharma Company?

GET THE FULL COMPANY
ANALYSIS BUNDLE FOR
Fosun Pharma

Full Company Analysis:

BCG	~~$15~~	$10
5 FORCES	~~$15~~	$10
CANVAS	~~$15~~	$10
4P's MIX	~~$15~~	$10
PESTLE	~~$15~~	$10
SWOT	~~$15~~	$10

What is Fosun Pharma's Sales and Marketing Strategy?

In a pivotal move that underscores its commitment to global health and innovation, Fosun Pharma announced in February 2025 the approval of its licensed product Daxxify® (DaxibotulinumtoxinA-lanm) in China, marking a significant entry into the aesthetic medicine market. This decision highlights a strategic shift from its historical focus primarily on pharmaceutical manufacturing and distribution to embracing high-value medical devices and innovative therapies, significantly reshaping its market presence.

What is Sales and Marketing Strategy of Fosun Pharma Company?

Shanghai Fosun Pharmaceutical (Group) Co., Ltd., commonly known as Fosun Pharma, was founded in 1994 and is headquartered in Shanghai, China. Its founders established the company with an original vision to be deeply rooted in China while expanding globally in the pharmaceutical and healthcare industry. Initially, the company focused on traditional pharmaceutical manufacturing and distribution, notably through its strategic alliance with Sinopharm Group Co., Ltd., which became the largest pharmaceutical distributor in China.

Today, Fosun Pharma's approach has evolved dramatically. While maintaining its strong domestic foundation, as evidenced by its 2024 operating revenue of RMB 41.07 billion, the company has strategically expanded its global footprint, with overseas revenue reaching RMB 11.30 billion in 2024, accounting for 27.51% of its total revenue. This transformation involves a detailed strategy for getting products to customers, employing diverse marketing tactics, carefully positioning its brand, and executing standout campaigns that reflect its '4IN' strategy: Innovation, Internationalization, Intelligentization, and Integration. This comprehensive Fosun Pharma business strategy aims to enhance its market share across various therapeutic areas.

The Fosun Pharma sales strategy is deeply intertwined with its product portfolio, focusing on innovative therapies and medical devices. The company's marketing strategy leverages digital channels for patient engagement and builds brand awareness for its medicines through targeted campaigns, particularly for its oncology drugs. Fosun Pharma's sales force effectiveness and training programs are crucial for its competitive sales tactics in the healthcare industry. Furthermore, its distribution and supply chain strategy ensures efficient market penetration, especially for biosimilars, and its R&D investment directly impacts its marketing efforts. Understanding the Fosun Pharma BCG Matrix can provide further insight into its product positioning and growth strategy.

Fosun Pharma's approach to building brand awareness for its medicines is multifaceted, utilizing key marketing channels that include both traditional and digital platforms. The company's digital marketing strategy for patient engagement is a cornerstone of its efforts to connect with healthcare providers and patients alike. In emerging markets, Fosun Pharma's strategy to increase sales involves adapting its marketing campaigns and sales approach for new drugs to local needs and regulatory environments. The company also emphasizes customer relationship management in marketing to foster loyalty and repeat business.

Fosun Pharma's partnerships play a vital role in its sales growth, enabling market access and co-promotion opportunities. The company sets ambitious sales targets and employs robust performance metrics to track its progress and ensure its sales and marketing approach for new drugs is effective. By focusing on innovation and internationalization, Fosun Pharma continues to refine its business strategy to capture greater market share and drive sustainable growth in the global healthcare landscape.

How Does Fosun Pharma Reach Its Customers?

Fosun Pharma employs a comprehensive sales strategy that integrates direct sales, extensive wholesale distribution, and strategic alliances to maximize its market reach. The company's pharmaceutical and medical device operations are concentrated in key international markets, including the United States, Europe, Africa, India, and Southeast Asia. This global presence is supported by an overseas commercialization team exceeding 1,000 employees as of late 2024, underscoring a significant investment in international sales capabilities.

The company's approach to sales channels is dynamic, adapting to market needs and technological advancements. This includes building localized sales platforms, such as the one launched in Nanning in February 2025 to enhance its presence in Southeast Asia. In established markets like the U.S., Fosun Pharma is expanding its self-operated generic drug team while also working with major distributors and group purchasing organizations, having 33 products available by the end of 2024. This dual approach of direct engagement and established partnerships is central to its market penetration strategy.

Furthermore, Fosun Pharma's commitment to expanding its global footprint is evident in its subsidiaries' operations. Sisram Medical, for instance, has grown its direct sales offices to 12, with direct sales revenue reaching 87% and its marketing network extending to over 110 countries. Strategic collaborations, like the joint venture in Saudi Arabia, are also crucial for increasing access to innovative products in the MENAT region. These efforts contribute to Fosun Pharma's overall growth strategy, with overseas revenue representing 27.51% of its total revenue in 2024, reflecting the success of its international sales and marketing approach for its diverse product portfolio.

Direct Sales Force Expansion

Fosun Pharma is actively building and expanding its direct sales teams, particularly in key overseas markets like the United States. This allows for more direct engagement with healthcare providers and a deeper understanding of local market needs, contributing to its overall business strategy.

Wholesale Distribution Networks

Leveraging established wholesale distribution networks is a cornerstone of Fosun Pharma's sales strategy, ensuring broad availability of its pharmaceutical and medical device products. This traditional channel remains vital for reaching a wide customer base efficiently.

Strategic Partnerships and Joint Ventures

The company actively pursues strategic partnerships and joint ventures to enhance market access and commercialization capabilities. These collaborations, such as the one in Saudi Arabia, are key to its growth strategy and expanding its market share for high-value products.

Digital Platform Development

Fosun Pharma is investing in digital platforms to support its sales and marketing efforts, exemplified by the new platform launched in Nanning for Southeast Asia. This reflects an evolving marketing strategy that embraces digital solutions for improved reach and engagement.

Global Market Penetration

Fosun Pharma's sales and marketing approach is designed for extensive global reach, with a particular focus on emerging markets. The company's commitment to these regions is a significant part of its overall business strategy.

Overseas commercialization team of over 1,000 employees as of late 2024.
Sales network in Africa spans over 40 countries and regions.
Sisram Medical's marketing network covers over 110 countries and regions.
Overseas revenue accounted for 27.51% of total revenue in 2024.
The company's international expansion is a key aspect of its Brief History of Fosun Pharma.

Complete Fosun Pharma Strategy Bundle

6 Full Frameworks, 1 Company – All Pre-Researched
Each Framework Fully Sourced with Real Company Data
Built for Strategy Courses, Case Studies & MBA Programs
Adapt to Your Assignment – No Starting from Scratch
6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's

What Marketing Tactics Does Fosun Pharma Use?

Fosun Pharma is increasingly focusing its marketing tactics on digital transformation and data-driven methodologies to enhance brand awareness, generate leads, and ultimately drive sales. The company is actively integrating Artificial Intelligence (AI) to boost efficiency and create a more cohesive ecosystem. A key component of this is its self-developed PharmAID decision intelligence platform, which leverages AI for intelligent sales personnel training and supports more precise marketing initiatives.

While specific details regarding traditional media campaigns for 2024-2025 are less emphasized in recent reports, the clear strategic direction points towards digital and data-centric approaches. Fosun Pharma's commitment to 'Intelligentization' within its '4IN' strategy highlights the pervasive application of AI across drug R&D, clinical applications, medical imaging, and marketing efforts. The company's objective is to accelerate the deeper integration of AI in marketing, customer service, and smart office solutions to improve both quality and operational efficiency.

Collaborations with AI pharmaceutical entities, such as Insilico Medicine since 2022 and DP Technology in January 2025 for AI-assisted drug R&D, underscore an innovative and experimental strategy in adopting advanced technologies. These partnerships implicitly bolster its marketing intelligence and targeting capabilities. This dedication to technological leadership and ongoing innovation, guided by digital and intelligent technologies, facilitates data connectivity and empowerment. This, in turn, leads to compliant, intelligent, and efficient global human resources digital solutions that can be effectively extended to marketing operations, shaping Fosun Pharma's sales and marketing approach for new drugs.

Digital Transformation Focus

Fosun Pharma is prioritizing digital transformation and data-driven strategies to enhance its marketing efforts and sales performance.

AI Integration

The company is actively embracing AI technology, notably through its PharmAID platform, to improve sales training and marketing precision.

'Intelligentization' Strategy

As part of its '4IN' strategy, Fosun Pharma is driving the application of AI across R&D, clinical use, medical imaging, and marketing.

AI Partnerships

Collaborations with AI firms like Insilico Medicine and DP Technology demonstrate a commitment to leveraging advanced technology for innovation and market insights.

Data-Driven Marketing

The emphasis on data connectivity and empowerment through intelligent technologies supports more effective and compliant marketing campaigns.

Efficiency and Quality Improvement

The goal is to enhance the quality and efficiency of marketing and customer service operations through intelligent solutions.

Key Marketing Channels and Tactics

Fosun Pharma's marketing strategy is heavily influenced by its commitment to technological advancement, aiming to create more precise and efficient customer engagement. This approach supports its overall Revenue Streams & Business Model of Fosun Pharma.

Digital Channels: Increased reliance on digital platforms for outreach and engagement.
AI-Powered Insights: Utilizing AI for targeted marketing campaigns and sales force optimization.
Data Analytics: Employing data to understand customer behavior and refine marketing messages.
Strategic Partnerships: Collaborating with technology firms to enhance marketing intelligence and capabilities.
Intelligentization: Integrating AI across various business functions, including marketing, to drive efficiency and quality.
Customer Relationship Management: Leveraging technology for improved customer interactions and loyalty.

From PESTLE Factors to Full Strategy Bundle

PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
Every Strategic Angle Covered – Nothing Left to Research
Pre-filled with Company-Specific Research
No Missing Sections for Your Case Study
One Download Covers Your Entire Company Analysis

How Is Fosun Pharma Positioned in the Market?

Fosun Pharma positions itself as a global innovation-driven pharmaceutical and healthcare group, with a strong foundation in China and a growing international footprint. Its brand messaging centers on 'Innovation for Good Health,' emphasizing a patient-centric approach focused on addressing unmet clinical needs. This core strategy guides its efforts in developing and delivering high-quality, accessible treatments worldwide.

The company differentiates its brand through robust research and development capabilities, particularly in key therapeutic areas such as oncology, immune-inflammatory disorders, and metabolic diseases. Fosun Pharma is actively investing in and advancing its technological leadership in areas like antibody and ADC platforms, cell therapies, and small molecule development. Furthermore, it is exploring next-generation therapeutic modalities, including radiopharmaceuticals, RNA therapeutics, gene editing, and AI-driven drug discovery, underscoring its commitment to cutting-edge innovation.

Innovation Focus

Fosun Pharma's brand is built on a foundation of innovation, targeting unmet clinical needs across critical disease areas. This focus drives its investment in advanced R&D platforms and novel therapeutic modalities.

Global Reach and Accessibility

The company aims to make high-quality, affordable treatments accessible globally. Its self-developed biosimilar, Han Qu You (Trastuzumab Injection), has achieved approval in over 50 countries and regions, benefiting more than 240,000 patients.

Strategic '4IN' Approach

Fosun Pharma consistently applies its '4IN' strategy: Innovation, Internationalization, Intelligentization, and Integration. This cohesive approach reinforces its identity as a forward-thinking and globally integrated healthcare leader across all operations.

Commitment to Sustainability and Value

Maintaining an MSCI ESG rating of 'A' in 2024 highlights its dedication to sustainability and social responsibility. In 2025, the company's share repurchase program signals strong confidence in its sustainable growth and inherent value.

The brand positioning resonates with its target audience by showcasing a commitment to innovation and the global availability of effective, affordable healthcare solutions. This approach is further supported by the company's strategic focus on understanding the Target Market of Fosun Pharma and tailoring its offerings accordingly. Fosun Pharma's sales strategy is intrinsically linked to this brand positioning, aiming to penetrate markets effectively by highlighting the clinical value and accessibility of its product portfolio.

Therapeutic Area Leadership

Fosun Pharma emphasizes its leadership in oncology, immune-inflammatory disorders, and metabolic diseases. This specialization allows for targeted marketing and sales efforts.

Technological Advancement

The brand highlights its investment in advanced platforms like ADCs and cell therapies. This technological edge is a key selling point in its marketing campaigns.

Patient-Centric Messaging

A core element of Fosun Pharma's brand is its patient-centered approach. Marketing efforts often focus on how its innovations directly benefit patient health and well-being.